Overview

Bioinformation Therapy for Lung Cancer

Status:
Completed
Trial end date:
2018-09-02
Target enrollment:
Participant gender:
Summary
The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable lung cancer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fuda Cancer Hospital, Guangzhou
Collaborator:
Shengxin Biotechnology Institute, Beijing
Treatments:
Pharmaceutical Solutions